Bingxin Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bingxin Lu has a total of 209 co-authors. Here are the top co-authors by number of shared publications:
- Chris Barnes
University College London
37 shared publications - Trevor A. Graham
Centre for Evolution and Cancer, Institute of Cancer Research, London, UK
32 shared publications - Andrea Sottoriva
Computational Biology Research Centre, Human Technopole, Milan, Italy
31 shared publications - Maximilian Mossner
Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
31 shared publications - William Charles Hemming Cross
The Rare Malignancies and Cancer Evolution Lab, School of Biological Sciences, University of Reading, Reading, UK
31 shared publications - Abhirup Banerjee
Division of Gastrointestinal Surgery, P D Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai, 400 016, India,
30 shared publications
Latest Publications
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per genomic bin copy number calls (gains=3, diploid=2, loss=1) for data presented in Figure 1.
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per genomic bin copy number calls (gains=3, diploid=2, loss=1) for data presented in Figure 1.
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per segment raw sWGS copy number data for patients presented in Figure 2.
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per segment raw sWGS copy number data for patients presented in Figure 2.
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 8 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per genomic bin copy number calls for single-cell data presented in Figure 3.
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 8 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per genomic bin copy number calls for single-cell data presented in Figure 3.
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 9 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Cohort information per sample for the longitudinal metastasis cohort (Figure 4), including description of organ, timepoint sampled, tumour stage at diagnosis, whether the sample is treatment naïve, if the sample was treated in the prior interval, the number of days and months elapsing since the first timepoint, in addition to per sample genomic metrics such as PGA, number of segments, patient ploidy, per sample GD classification and overall patient GD classification.
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 9 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Cohort information per sample for the longitudinal metastasis cohort (Figure 4), including description of organ, timepoint sampled, tumour stage at diagnosis, whether the sample is treatment naïve, if the sample was treated in the prior interval, the number of days and months elapsing since the first timepoint, in addition to per sample genomic metrics such as PGA, number of segments, patient ploidy, per sample GD classification and overall patient GD classification.
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Note on Modelling 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Supplementary note where we describe the gland mathematical modelling and simulations
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Note on Modelling 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Supplementary note where we describe the gland mathematical modelling and simulations
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Clinical information for CRC cohort presented in Figure 1.
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Clinical information for CRC cohort presented in Figure 1.
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 10 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per sample, per segment, raw copy number data (log2 ratios) and integer calls for the longitudinal metastasis cohort presented in Figure 4.
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 10 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per sample, per segment, raw copy number data (log2 ratios) and integer calls for the longitudinal metastasis cohort presented in Figure 4.
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per patient clinical information for the CRC cases presented in Figure 2.
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per patient clinical information for the CRC cases presented in Figure 2.
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Pairwise comparison metrics for data presented in Figure 1.
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Pairwise comparison metrics for data presented in Figure 1.
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per segment Sequenza copy number data and calls for patients presented in Figure 2.
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
Per segment Sequenza copy number data and calls for patients presented in Figure 2.